AbbVie
ABBV
1,727 hedge funds and large institutions have $71.3B invested in AbbVie in 2017 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 650 increasing their positions, 743 reducing their positions, and 71 closing their positions.
73% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 71
20% more call options, than puts
Call options by funds: $1.29B | Put options by funds: $1.07B
2% more funds holding
Funds holding: 1,692 → 1,727 (+35)
1.45% more ownership
Funds ownership: 67.19% → 68.63% (+1.4%)
4% more capital invested
Capital invested by funds: $68.3B → $71.3B (+$2.95B)
2% less funds holding in top 10
Funds holding in top 10: 85 → 83 (-2)
13% less repeat investments, than reductions
Existing positions increased: 650 | Existing positions reduced: 743
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.55B |
| 2 |
Morgan Stanley
New York
|
+$258M |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$244M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$168M |
| 5 |
D.E. Shaw & Co
New York
|
+$157M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
-$372M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$293M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$179M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$131M |
| 5 |
Two Sigma Advisers
New York
|
-$128M |
ABBV Hedge Fund Activity: Q1 2017 in Review
1,727 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q1 2017, worth a combined $71.3B — up 4.3% from $68.3B a quarter earlier.
Buyers outnumbered sellers: 123 funds opened new ABBV positions and 71 closed out — a net gain of 52 holders — while 650 added to existing stakes and 743 trimmed.
The largest buyer was BlackRock, adding an estimated $5.55B. The largest seller was Highfields Capital Management, exiting entirely with an estimated $372M sold.
- 1,727 institutional investors held AbbVie (ABBV) as of Q1 2017, up from 1,692 in Q4 2016.
- Funds reported $71.3B of AbbVie stock for Q1 2017, up 4.3% quarter-over-quarter.
- 123 funds opened new AbbVie positions in Q1 2017 and 71 closed out, a net change of +52 holders.
- The largest AbbVie buyer in Q1 2017 was BlackRock, an estimated $5.55B added.
- The largest AbbVie seller in Q1 2017 was Highfields Capital Management, an estimated $372M sold.
Based on aggregated 13F filings for Q1 2017.